Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-05-11
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Sobi, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT05369208
- Locations
- ๐ฏ๐ต
Sobi Site 105, Toyohashi, Aichi, Japan
๐ฏ๐ตSobi Site 119, Kumamoto-shi, Kumamoto, Japan
๐ฏ๐ตSobi Site 101, Shiwa-gun, Iwata, Japan
Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of โค6 Months
- First Posted Date
- 2021-09-16
- Last Posted Date
- 2021-10-22
- Lead Sponsor
- Sobi, Inc.
- Registration Number
- NCT05046327
Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim
- First Posted Date
- 2020-11-20
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Sobi, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04638829
- Locations
- ๐บ๐ธ
Sobi Site 110, Tucson, Arizona, United States
๐บ๐ธSobi Site 104, Rock Hill, South Carolina, United States
๐บ๐ธSobi Site 126, Chicago, Illinois, United States
Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for โฅ6 Months
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-08-18
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- Sobi, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT04516967
- Locations
- ๐บ๐ธ
Site 116, Atlanta, Georgia, United States
๐บ๐ธSite 114, Jackson, Mississippi, United States
๐บ๐ธSite 121, Philadelphia, Pennsylvania, United States
Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure
Terminated
- Conditions
- First Posted Date
- 2018-06-13
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Sobi, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT03554759
- Locations
- ๐บ๐ธ
Dova Site, Philadelphia, Pennsylvania, United States
๐บ๐ธDova Study Site, Milwaukee, Wisconsin, United States
๐บ๐ธDova Study SIte, Roanoke, Virginia, United States
Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-03-20
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Sobi, Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT03471078
- Locations
- ๐บ๐ฆ
Dova Site, Vinnytsia, Ukraine
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
- First Posted Date
- 2017-10-31
- Last Posted Date
- 2020-04-15
- Lead Sponsor
- Sobi, Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT03326843
- Locations
- ๐บ๐ธ
Dova Site, Milwaukee, Wisconsin, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath